Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 18
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03632291 | Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients | ||
| NCT03149211 | To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults | ||
| NCT04620304 | Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients | ||
| NCT04406727 | UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection | ||
| NCT01518881 | Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion | ||
| NCT03743376 | The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients | ||
| NCT05056974 | A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs | ||
| NCT02346760 | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers | ||
| NCT03595995 | A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 | ||
| NCT04175704 | Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria | ||
| NCT05298215 | A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria | ||
| NCT03729219 | Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC) | ||
| NCT04620291 | Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults | ||
| NCT03164447 | UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients | ||
| NCT02041715 | Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802 | ||
| NCT04041362 | the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients | ||
| NCT02369146 | To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults | ||
| NCT03013881 | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers |
